“…The presence of only high level of circulating LEP cannot be sufficient to produce excessive growth promotion leading to cancer; it must need the receptor. The over-expression of LEPR, as we found in one of our previous studies with breast cancer (Al-Shibli et al, 2017), and by many authors with various cancers (Aloulou et al, 2008; Ishikawa, Kitayama & Nagawa, 2004; Mu et al, 2014; Uchiyama et al, 2011; Uddin et al, 2009b; Jardé et al, 2008; Miyoshi et al, 2006; Uddin et al, 2009a; Hoon Kim et al, 2008) must be significant in the carcinogenic influence of obesity or LEP. However, the claims by various authors about the effect of LEP-LEPR system in colon cancer are confounding, and maybe even contradictory (Hoda et al, 2007; Uchiyama et al, 2011; Stattin et al, 2003; Stattin et al, 2004; Bolukbas et al, 2004; Kumor et al, 2009; Sălăgeanu et al, 2010; Kosova et al, 2013).…”